✦ LIBER ✦

A low distribution volume as a determinant of efficacy and safety for histamine (H1 antagonists

✍ Scribed by Jean-Paul Tillement

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting and Establishing the Clinical

✍ Dr Glenis Scadding 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 162 KB

Antiobesity evaluation of histamine H3re

✍ A. A. Hancock; M. S. Diehl; T. A. Fey; E. N. Bush; R. Faghih; T. R. Miller; K. M 📂 Article 📅 2005 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 179 KB

1118 Preclinical efficacy and antiallerg

✍ KREUTNER, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 244 KB

1120 Preclinical cardiovascular and CNS

✍ HEY, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Efficacy and safety of low dosage amanta

✍ Peter D. Reuman; David I. Bernstein; Michael C. Keefer; Elizabeth C. Young; Jame 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 745 KB

Reversal of histamine-induced bronchocon

✍ RE Ferner; C. Ward; C. Kelly; M. Connolly; DN Bateman; MD Rawlins 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB